Tuesday, May 1, 2012

Heart Test Spots Sudden Death Risk in Young Athletes

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- Electrocardiograph (EKG) screening of young athletes can help identify those at risk for sudden cardiac death, according to a new study.

Researchers screened nearly more than 1,300 young athletes and conducted EKGs on 586 of them based on medical history, family history, a physical exam or prior EKG. Six athletes were found to have a heart disorder known to cause sudden cardiac death.

The study looked at how sensitive and specific the EKGs were as tests. Sensitivity refers to how confidently a doctor can rule out a problem and that it isn't a "false negative." Specificity refers to how sure a doctor can be that a positive test result is accurate.

For medical history alone, the sensitivity and specificity to detect heart disorders linked to sudden cardiac death were 33 percent and 69 percent. For physical exam, the figures were 16 percent and 91 percent. For EKG, sensitivity was 100 percent and specificity was 95 percent.

Half of disorders known to cause sudden cardiac death were detected by EKG alone, said Dr. Jessie Fudge, who is completing a fellowship in primary care sports medicine at the University of Washington in Seattle.

"

View the Original article

Votrient Approved to Treat Cancer That Begins in Soft Tissue

background:url(http://l.yimg.com/a/p/us/news/editorial/a/5b/a5ba32682eb601fb573b57542c19b9c1.png);width:115px;height:25px;margin-left:50px;margin-top:7px

View the Original article

More Babies Today Have Irregular Head Shape: Expert

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- The incidence of babies with irregular head shapes, such as a flattened section in the back of the skull, have increased in the United States since the Back to Sleep campaign was introduced in 1994 to prevent sudden infant death syndrome, an expert says.

"There's no doubt that as we as a country began putting babies to sleep on their backs, the incidence of

View the Original article

Blood Clot Risk for Outpatients Needs More Attention: Study

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- People undergoing outpatient surgery should be warned about their risk for dangerous blood clots, according to a new study that finds the risk is higher among groups including, but not limited to, those who are older or obese.

The University of Michigan researchers found that one in 84 patients considered high-risk suffers a blood clot after outpatient surgery. More than 60 percent of operations are currently performed as outpatient procedures, according to background information in a university new release.

"Outpatient surgery now includes a greater variety of procedures, from plastic surgery to cancer operations and orthopedic surgery, and not all patients are young, healthy individuals," lead study author Dr. Christopher Pannucci, a University of Michigan plastic surgeon, said in the news release. "These data are in stark contrast to provider and patient expectations that outpatient surgery is a low-risk event."

The researchers looked at more than 200,000 outpatient surgeries across the United States, and found that most patients had more than one risk factor for developing a clot, known as a venous thromboembolism. These clots form in the veins (deep vein thrombosis or DVT) and can be deadly if they travel to the lungs (pulmonary embolism).

The study, published online April 13 in Annals of Surgery, concluded that improved patient screening is needed to prevent these dangerous blood clots. Factors to consider include:

Age Surgery lengthCurrent pregnancyActive cancerType of surgical procedure

The researchers, who have created a tool that clinicians can use to measure a patient's risk for blood clot following outpatient surgery, said their findings could help improve how patients are informed about their surgical risks.

More information

The U.S. Agency for Healthcare Research and Quality has more about the treatment and prevention of blood clots.



View the Original article

Adjusting Your Attitude About Chronic Pain May Help You Sleep

background:url(http://l.yimg.com/a/p/us/news/editorial/a/5b/a5ba32682eb601fb573b57542c19b9c1.png);width:115px;height:25px;margin-left:50px;margin-top:7px

View the Original article

Health Highlights: April 27, 2012

HealthDay – 16 hrs ago Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

FDA Sends Warning to Supplements Companies

Ten companies that make and distribute dietary supplements containing dimethylamylamine (DMAA) have been sent warning letters for marketing products that lack safety evidence, the U.S. Food and Drug Administration said Friday.

DMAA -- also referred to as 1,3-dimethylamylamine, methylhexanamine, or geranium extract -- is often touted as a "natural" stimulant.

The companies that received warning letters and the names of their products are: Exclusive Supplements for Biorhythm SSIN Juice; Fahrenheit Nutrition for Lean Efx; Gaspari Nutrition for Spirodex; iSatori Global Technologies, LLC for PWR; Muscle Warfare, Inc. for Napalm; MuscleMeds Perfomance Technologies for Code Red; Nutrex Research for Hemo Rage Black, Lipo-6 Black Ultra Concentrate, Lipo-6 Black, Lipo-6 Black Hers Ultra, Concentrate, andLipo-6 Black Hers; SEI Pharmaceuticals for MethylHex 4,2; SNI, LLC for Nitric Blast; and USP Labs, LLC for Oxy Elite Pro and Jack3D.

"Before marketing products containing DMAA, manufacturers and distributors have a responsibility under the law to provide evidence of the safety of their products. They haven't done that and that makes the products adulterated," Daniel Fabricant, director of the FDA's Dietary Supplement Program, said in an agency news release.

-----

Bed Bugs Blamed for Monkeypox Scare on U.S. Passenger Plane

Bed bugs, not the monkeypox virus, may have caused the rash on a passenger that resulted in a two-hour quarantine of a Delta Airlines plan in Chicago Thursday.

Monkeypox is a rare and sometimes fatal disease similar to smallpox.

Officers wearing Hazmat suits boarded Flight 3163 to examine and take photographs of the rash on 50-year-old Lise Sievers of Red Wing, Minn., who was returning home from Uganda, ABC News reported.

"Medical staff at CDC and the Chicago Department of Public Health reviewed the case and, based on the patient's symptoms and photographs of the rash, it does not appear that the signs and symptoms are consistent with a monkeypox infection," the U.S. Centers for Disease Control and Prevention said in a statement. "The ill passenger was advised to seek medical care and the rest of the passengers were released from the plane."

"It's just a case of bed bugs," Sievers said after she exited the plane, ABC News reported.

-----

Holstein with Mad Cow Disease Put Down After Showing Signs of Illness: USDA

A dairy cow in California that was found to have mad cow disease was euthanized after it become lame and started lying down, U.S. Department of Agriculture officials said Thursday.

They also said that the Holstein cow from a dairy farm in Tulare County -- the nation's leading dairy-producing county -- was 10 years and seven months old. That contradicts a spokesman for U.S. Rep. Devin Nunes of California who said Wednesday that the cow was 5 years old, the Associated Press reported.

Routine testing at a transfer facility detected mad cow disease (bovine spongiform encephalopathy -- BSE) in the cow. The animal was never destined for the meat market and posed no threat to the food supply, officials said.

The cow had atypical BSE, which is caused by a random mutation. The last two cases of BSE in the U.S. were atypical as well, the AP reported.

-----

Don't Use Hepatitis C Drug With HIV Drugs: FDA

The hepatitis C medicine Victrelis (boceprevir) should not be taken with certain ritonavir-boosted HIV protease inhibitor drugs, the U.S. Food and Drug Administration said Thursday.

Taking these medicines at the same time could reduce their effectiveness and allow levels of the hepatitis C virus or HIV in the blood to increase.

Ritonavir-boosted HIV protease inhibitors include ritonavir-boosted Reyataz (atazanavir), ritonavir-boosted Prezista (darunavir), and Kaletra (lopinavir/ritonavir).

"Patients should not stop taking any of their hepatitis C or HIV medicines without talking to their healthcare professional. Patients should contact their healthcare professional with any questions or concerns," the FDA said.

"Healthcare professionals who started patients infected with both chronic HCV and HIV on Victrelis while the patient was taking antiretroviral therapy containing one of these ritonavir-boosted protease inhibitors should closely monitor patients for treatment response (no HCV virus detected in the blood) and for potential HCV or HIV virologic rebound (HCV or HIV virus is detected in the blood again after becoming undetectable)," the FDA advised.

-----

Consumers, Employers to Get $1.3 Billion in Health Insurance Rebates

Under the new U.S. health care law, more than 3 million health insurance policyholders and thousands of employers will receive a total of $1.3 billion in rebates this year, according to a report released Thursday by the Kaiser Family Foundation, a nonpartisan research group.

The law requires insurance companies to spend at least 80 percent of the premiums they collect on medical care and quality improvement or return the difference to individuals or employers, the Associated Press reported.

Insurance companies must notify policyholders about the rebates and pay them by Aug. 1. Some companies have already started issuing rebates.

More than 3 million individual healthy insurance policyholders will receive a total of $426 million, which works out to an average of $127 per person, the AP reported.

On a state-by-state basis, the largest rebates will go to individuals and employers in Texas ($186 million) and Florida ($149 million). Hawaii is the only state in which insurers are not expected to issue rebates.

Rebates totaling $377 million will be sent out to small employers with plans covering nearly 5 million people. Employers are not required to pass their rebates on to workers, and are also allowed to take them as a discount on next year's premiums, the AP reported.

The Kaiser report's findings are based on an analysis of insurance industry filings with state health insurance commissioners.

The rebates are one of the most tangible benefits that consumers have seen to date from the Obama administration's health care law, according to Larry Levitt, a Kaiser Family Foundation expert on private insurance, the AP reported.

However, the insurance industry says new benefits and other requirements of the health care law will likely drive up premiums, negating any consumer benefit from the rebates.

But the Kaiser report said that the new health care law has "provided an incentive for insurers to seek lower premium increases than they would have otherwise," according to the report. "This 'sentinel' effect on premiums has likely produced more savings for consumers and employers than the rebates themselves."

-----

200 Now Sickened in Tuna-Linked Salmonella Outbreak

A salmonella outbreak linked to a frozen yellowfin tuna product has now sickened 200 people in 21 states and the District of Columbia, the U.S. Centers for Disease Control and Prevention said late Thursday.

In a statement, the agency said 28 people have been hospitalized but there have been no deaths reported.

The CDC says it is now including two types of salmonella in the "outbreak strains" -- Salmonella Bareilly (190 cases) and Salmonella Nchanga (10 cases).

On April 16, nearly 59,000 pounds of tuna product linked to the outbreak -- labeled Nakaochi Scrape AA or AAA -- were recalled by Moon Marine USA Corp. of Cupertino, Calif. The product, which is scraped off fish bones, was sold to grocery stores and restaurants to make dishes such as sushi, sashimi and ceviche.

As reported early in the outbreak by the Associated Press, many people who became ill reported eating raw tuna in sushi as "spicy tuna."

As of Thursday, the CDC said illnesses linked Salmonella Bareilly had been reported in: Alabama (2), Arkansas (1), Connecticut (8), District of Columbia (2), Florida (1), Georgia (9), Illinois (15), Louisiana (3), Maryland (20), Massachusetts (24), Mississippi (2), Missouri (4), New Jersey (18), New York (33), North Carolina (3), Pennsylvania (7), Rhode Island (6), South Carolina (3), Texas (4), Virginia (9), Vermont (1) and Wisconsin (145). Illnesses linked to Salmonella Nchanga had been reported in Georgia (2), New Jersey (1), New York (5), Virginia (1), and Wisconsin (1), the CDC said.

The CDC noted that salmonella illness is often serious for infants, older adults, pregnant women and persons with impaired immune systems, and these individuals should not eat raw or partially cooked fish or shellfish.

-----



View the Original article

Some Schools Don't Let Kids Carry Asthma Inhalers

'modId':'mediatabs_nmid_1_conv_prom','isPreLoad':0,'enableMediaTabEvent':0,'pageSize':12,'numFriends':null,'notificationCount':0,'property':'News','learnMorePath':'/activity-learn-more/','friendbarNotification':'0','friendbarRollup':'0','moduleConf':YAHOO.Media.Facebook.ModuleConf,'friendIdList':

View the Original article

Levaquin Approved to Treat or Prevent Plague

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- Approval of the antibiotic Levaquin (levofloxacin) has been expanded by the U.S. Food and Drug Administration to include plague, a rare but deadly bacterial infection.

The disease is extremely rare in the United States, and only about 1,000 to 2,000 cases occur each year across the globe, the agency said in a news release. The three most common forms of plague include bubonic (affecting the lymph nodes), pneumonic (lungs) and septicemic (blood stream).

Animals are most frequently infected, although plague can be spread to people by fleas, contact with infected animals or other people, or by exposure in the laboratory. The bacterium that causes plague, Yersinia pestis, is considered a potential bioterrorism agent, the FDA said.

Levaquin was tested under the agency's Animal Efficacy Rule, which allows findings from carefully controlled tests in animals to be applied to people. It would not be ethical or feasible to conduct clinical testing of the drug for this purpose in people, the FDA said.

Known side effects of Levaquin include nausea, headache, diarrhea, insomnia, constipation and dizziness. More serious but rare adverse reactions could include tendinitis and tendon rupture, allergic reactions, liver damage, blood and nervous system problems, and abnormal heart rhythm, the agency said.

Levaquin is produced by Raritan, N.J.-based Janssen Pharmaceuticals, a unit of Johnson & Johnson.

More information

Medline Plus has more about Levaquin.



View the Original article

Taking Away Car Keys Can Be Tough for Older Drivers

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- Driving can be a major factor in elderly people's quality of life, affecting their mental health and overall well-being, an expert says.

If an older driver's diminishing abilities behind the wheel are cause for concern, the issue needs to be dealt with compassionately to preserve the person's dignity and keep them and others safe, says Dr. Kavon Young, a geriatric specialist with the Harris County Hospital District in Texas.

"Aging is a process where so many things are lost," Young said in a hospital district news release. "Part of what seniors try to hold onto is their independence -- the independence to make decisions about their health, their future and their driving. To them, driving is more than a way to get from one place to another."

Being forced to hang up the car keys can harm a senior's self-esteem and may trigger depression, anxiety and loneliness, Young said. In some cases, a person may feel isolated and not want to keep up with their medical care.

"A lot of factors ... go into discussing driving with seniors because the goal is to maintain their dignity in the process. These are adults and should be treated as such," said Young, an assistant professor in the division of geriatric and palliative medicine at the University of Texas Health Science Center at Houston.

If you're concerned about an elderly loved one's ability to drive safely, have an open and honest talk about driving and safety concerns, Young suggested. Most seniors will limit their driving if they don't feel safe, but some may not be aware of vision and memory deficits, and will not restrict their driving.

Young said signs that an elderly person's driving could be cause for concern include: longer drive times for short distances; not obeying traffic signs; forgetting destinations or locations; hitting curbs; and being angry or anxious when driving.

"Start the discussion early and agree that you won't make a decision based on one particular event," Young said. "Having this agreement will take the pressure off the senior. Sometimes family members or caregivers get upset and decide to stop all driving privileges, which can be traumatic for the senior."

In cases where an elderly person's driving abilities are a concern, you can suggest that they limit drives to short distances; drive only to familiar places; avoid driving at night; avoid driving during bad weather; and make use of a chauffeur list that includes family and friends.

More information

The U.S. National Institute on Aging has more about older drivers.



View the Original article

Study Recommends Putting Your Left Face Forward

HealthDay – 16 hrs ago FRIDAY, April 27 (HealthDay News) -- People show more emotion on the left side of their face, and that may help explain why that side typically appears more pleasant to others, researchers say.

Scientists from Wake Forest University said the findings may also help explain why portraits painted by Western artists often feature left-side profiles. The report is scheduled for online publication in the journal Experimental Brain Research.

"Our results suggest that posers' left cheeks tend to exhibit a greater intensity of emotion, which observers find more aesthetically pleasing," study authors Kelsey Blackburn and James Schirillo, of Wake Forest University, wrote in a journal news release. The new findings support "the notions of lateralized emotion and right hemispheric dominance with the right side of the brain controlling the left side of the face during emotional expression," they added.

For the study, the researchers showed study participants black-and-white profile photos. Some of the profiles were original photos, while others were mirror-reversed images. Participants rated the pleasantness of both sides of people's faces.

The results showed that the left side of both men's and women's faces were more aesthetically pleasing. This was true for the original photos as well as the mirror-reversed images.

Because people's pupils enlarge or dilate in response to interesting stimuli, the researchers confirmed their findings by measuring participants' pupil sizes. They found pupil size increased along with pleasantness ratings.

More information

The American Psychological Association has more about facial expressions.



View the Original article

Rights defender thorn in China's side

'modId':'mediatabs_nmid_1_conv_prom','isPreLoad':0,'enableMediaTabEvent':0,'pageSize':12,'numFriends':null,'notificationCount':0,'property':'News','learnMorePath':'/activity-learn-more/','friendbarNotification':'0','friendbarRollup':'0','moduleConf':YAHOO.Media.Facebook.ModuleConf,'friendIdList':

View the Original article

Rights defender thorn in China's side

'modId':'mediatabs_nmid_1_conv_prom','isPreLoad':0,'enableMediaTabEvent':0,'pageSize':12,'numFriends':null,'notificationCount':0,'property':'News','learnMorePath':'/activity-learn-more/','friendbarNotification':'0','friendbarRollup':'0','moduleConf':YAHOO.Media.Facebook.ModuleConf,'friendIdList':

View the Original article